Order Article Reprints

Kaur H, Chaudhary N, Modgil V, Kalia M, Kant V, Mohan B, Bhatia A, Taneja N. In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli. Antibiotics. 2023; 12(1):110. https://doi.org/10.3390/antibiotics12010110

Kaur, Harpreet, Naveen Chaudhary, Vinay Modgil, Manmohit Kalia, Vishal Kant, Balvinder Mohan, Alka Bhatia, and Neelam Taneja. 2023. "In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli" Antibiotics 12, no. 1: 110. https://doi.org/10.3390/antibiotics12010110

Kaur, H., Chaudhary, N., Modgil, V., Kalia, M., Kant, V., Mohan, B., Bhatia, A., & Taneja, N. (2023). In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli. Antibiotics, 12(1), 110. https://doi.org/10.3390/antibiotics12010110